Skip to content

Ouabain

CARDIOVASCULAR SYSTEM

Also known as: acocantherin, astrobain, g-strophanthin, gratibain, gratus strophanthin, kombetin, ouabaine, purostrophan, strophalen, uabaina, uabanin

YEAR INTRODUCED approvedATC C01AC01

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Ouabain is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1865. DrugCentral lists 4 molecular targets, including ATP1A2, STAT3 and KCNH2.

  • Molecular targets: ATP1A2, STAT3, KCNH2 and ATP1A1 (4 listed in DrugCentral).
  • ATC code: C01AC01 (Strophanthus glycosides).
  • Molecular formula: C29H44O12; molecular weight 584.66 g/mol.

Mechanism & targets

Molecular targets (4)

TargetGeneActionActivity
Sodium/potassium-transporting ATPase subunit alpha-2ATP1A2unknownIC50 6.17
Signal transducer and activator of transcription 3STAT3unknownIC50 5.94
Potassium voltage-gated channel subfamily H member 2KCNH2unknownIC50 5.01
Sodium/potassium-transporting ATPase subunit alpha-1ATP1A1unknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1865-01-01YEAR INTRODUCED——

ATC classification

ATC codeTherapeutic hierarchy
C01AC01CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › CARDIAC GLYCOSIDES › Strophanthus glycosides

Chemical structure

Molecular formulaC29H44O12
Molecular weight584.66 g/mol
CAS number—
InChIKeyLPMXVESGRSUGHW-HBYQJFLCSA-N
PubChem CID439501
C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C2=CC(=O)OC2)[C@H](O)[C@H](O)[C@H]1O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Ouabain work?

Its molecular targets in DrugCentral include ATP1A2, STAT3, KCNH2 and ATP1A1.

When was Ouabain first approved?

Ouabain was first approved by the YEAR INTRODUCED in 1865.

What is the chemical formula of Ouabain?

Ouabain has the molecular formula C29H44O12 and a molecular weight of 584.66 g/mol.

Browse: all drugs starting with O · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1865-01-01
AgencyYEAR INTRODUCED
Targets4
Indications0
FormulaC29H44O12
DrugCentral ID2004
Interactive profile